In contrast, HMGA1, LRFN4, SLC2A1, and ERO1A exhibited significantly higher expression levels in NSCLC patients in pathologic T3-T4 stages compared to those in T1-T2 pathologic stages (Figure 6A-C). This evidence concerns the gene HMGA1 and non-small cell lung carcinoma.